LA
WST icon

Lee Ainslie’s West Pharmaceutical WST Stock Holding History

Lee Ainslie’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-994
Closed -$393K – 480
2024
Q1 		$393K Buy
+994
New +$368K 0.01% 280
2021
Q4 		– Sell
-1,645
Closed -$698K – 636
2021
Q3 		$698K Buy
1,645
+1,558
+1,791% +$657K 0.01% 390
2021
Q2 		$31K Buy
+87
New +$28.7K ﹤0.01% 645
2019
Q2 		– Sell
-98,230
Closed -$10.8M – 355
2019
Q1 		$10.8M Sell
98,230
-1,720
-2% -$179K 0.14% 84
2018
Q4 		$9.8M Buy
99,950
+57,790
+137% +$6.27M 0.14% 81
2018
Q3 		$5.21M Buy
+42,160
New +$4.73M 0.06% 174

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lee Ainslie's WST Position: Q2 2024 in Review

Lee Ainslie sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 994 shares — an estimated $393K sold.

Lee Ainslie first reported a position in WST in Q3 2018 and held it in 6 quarters. The position peaked at $10.8M in Q1 2019. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Lee Ainslie reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Lee Ainslie sold 994 West Pharmaceutical shares in Q2 2024, an estimated $393K.
  • Lee Ainslie first reported a position in West Pharmaceutical in Q3 2018 and held it in 6 quarters.
  • Lee Ainslie's West Pharmaceutical position peaked at $10.8M in Q1 2019.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Maverick Capital's 13F filing for Q2 2024, filed 14 Aug 2024.